Biocept reported $9.61M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Becton, Dickinson and BDX:US $ 2305M 118M
Biocept BIOC:US $ 9.61M 3.4M
General Electric GE:US $ 4211M 852M
Illumina ILMN:US $ 815M 2M
Quest Diagnostics DGX:US $ 968M 97M
Thermo Fisher Scientific TMO:US $ 5464M 210M